Federal Register / Vol. 82, No. 176 / Wednesday, September 13, 2017 / Notices 43027 

Technology Transfer, 31 Center Drive 

Room 4A29, MSC2479, Bethesda, MD 

20892–2479; telephone: 301–402–5579. 

A signed Confidential Disclosure 

Agreement may be required to receive 

copies of the patent applications. 

SUPPLEMENTARY INFORMATION: The 

inventions listed below are owned by an 

agency of the U.S. Government and are 

available for licensing in the U.S. in 

accordance with 35 U.S.C. 209 and 37 

CFR part 404 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. A description of the 

technology available for licensing 

follows. 

Pyrophosphate Analog HIV-1 Reverse 

Transcriptase Inhibitors 

Description of Technology: The 

invention relates to compounds that 

inhibit HIV-1 DNA synthesis mediated 

by reverse transcriptase (RT). HIV-1 

DNA synthesis by RT utilizes 

deoxynucleoside 5′-triphosphate (dNTP) 

as substrate and like many other 

enzymes, the reaction is reversible. 

Pyrophosphate analogs like 

imidodiphosphate strongly promote 

reverse reaction dNTP products 

containing the imidodiphosphate group 

instead of the naturally occurring 

pyrophosphate group. This 

imidodiphosphate-containing dNTP was 

found to be a potent inhibitor of the 

forward RT reaction. Whereas 

pyrophosphorolysis is limited by a 

nonchemical step, replacing the 

bridging oxygen of pyrophosphate with 

an imido group resulted in a change in 

the rate-limiting step, so that the 

imidodiphosphate-dependent reverse 

reaction was limited by chemistry. 

There exists, then, the potential to use 

pyrophosphate analogs therapeutically. 

Potential Commercial Applications: 

• Anti-microbial. 

• HIV therapeutic. 

Development Stage: 

• In vitro data available. 

Inventors: Samuel Wilson, William 

Beard, David Dion Shock (all of NIEHS). 

Intellectual Property: HHS Reference 

No. E–210–2017/0–US–01. 

• U.S. Provisional Patent Application 

62/542,600 filed August 8, 2017. 

Licensing Contact: Michael 

Shmilovich, Esq, CLP; 301–435–5019; 

shmilovm@nih.gov. 

Collaborative Research Opportunity: 

The National Institute of Environmental 

Health Sciences seeks statements of 

capability or interest from parties 

interested in collaborative research to 

further develop and evaluate, please 

contact Sally E. Tilotta, Ph.D., Director, 

Office of Technology Transfer, National 

Institute of Environmental Health 

Sciences, Phone: (919) 316–4526; 

sally.tilotta@nih.gov. 

Dated: September 7, 2017. 

Michael Shmilovich, 

Senior Licensing and Patenting Manager, 

National Heart, Lung, and Blood Institute, 

Office of Technology Transfer and 

Development. 

[FR Doc. 2017–19315 Filed 9–12–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Shared 

Instruments: NMR spectrometers and X-ray 

crystallography/scattering. 

Date: October 3, 2017. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: David R Jollie, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4150, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1722, jollieda@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Shared 

Instruments: NMR spectrometers and X-ray 

crystallography/scattering. 

Date: October 3, 2017. 

Time: 3:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: James W Mack, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4154, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

2037, mackj2@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group 

Community Influences on Health Behavior 

Study Section. 

Date: October 4–5, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Plaza Hotel, 10 Thomas 

Circle, NW., Washington, DC 20005. 

Contact Person: Tasmeen Weik, DRPH, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3141, 

Bethesda, MD 20892, 301–827–6480, weikts@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Lymphatics 

in Health and Disease in the Digestive 

System, Kidney and Urinary Tract. 

Date: October 4, 2017. 

Time: 2:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Jianxin Hu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2156, 

Bethesda, MD 20892, 301–827–4417, 

jianxinh@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group Neurogenesis and Cell Fate 

Study Section. 

Date: October 5, 2017. 

Time: 8:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Crystal City, 2799 

Jefferson Davis Highway, Arlington, VA 

22202. 

Contact Person: Joanne T Fujii, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4184, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1178, fujiij@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group Developmental Therapeutics Study 

Section. 

Date: October 5–6, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Alexandria Old 

Town, 1900 Diagonal Road, Alexandria, VA 

22314. 

Contact Person: Sharon K Gubanich, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301) 408– 

9512, gubanics@csr.nih.gov. 

Name of Committee: Interdisciplinary 

Molecular Sciences and Training Integrated 

Review Group Enabling Bioanalytical and 

Imaging Technologies Study Section. 

Date: October 5–6, 2017. 


sradovich on DSK3GMQ082PROD with NOTICES
43028 Federal Register / Vol. 82, No. 176 / Wednesday, September 13, 2017 / Notices 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Washington, DC 

Dupont Circle Hotel, 1143 New Hampshire 

Ave NW., Washington, DC 20037. 

Contact Person: Kenneth Ryan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3218, 

MSC 7717, Bethesda, MD 20892, 301–435– 

0229, kenneth.ryan@nih.hhs.gov. 

Name of Committee: Oncology 1-Basic 

Translational Integrated Review Group 

Molecular Oncogenesis Study Section. 

Date: October 5–6, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Lorien Hotel & Spa, 1600 King 

Street, Alexandria, VA 22314. 

Contact Person: Nywana Sizemore, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6204, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1718, sizemoren@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group Biophysics of Neural Systems 

Study Section. 

Date: October 5, 2017. 

Time: 8:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Monaco Baltimore, 2 North 

Charles Street, Baltimore, MD 21201. 

Contact Person: Geoffrey G Schofield, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040–A, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1235, geoffreys@csr.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group 

Behavioral Genetics and Epidemiology Study 

Section. 

Date: October 5, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Plaza Hotel, 10 Thomas 

Circle, NW., Washington, DC 20005. 

Contact Person: George Vogler, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3140, 

MSC 7770, Bethesda, MD 20892, (301) 237– 

2693, voglergp@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group 

Psychosocial Development, Risk and 

Prevention Study Section. 

Date: October 5–6, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Anna L Riley, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7759, Bethesda, MD 20892, 301–435– 

2889, rileyann@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group Biobehavioral Regulation, Learning 

and Ethology Study Section. 

Date: October 5–6, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Pier 2620 Hotel Fisherman’s Wharf, 

2620 Jones Street, San Francisco, CA 94133. 

Contact Person: Unja Hayes, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, Center for Scientific Review, 6701 

Rockledge Drive, Bethesda, MD 20892, 301– 

827–6830, unja.hayes@nih.gov. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences Integrated Review Group 

Skeletal Biology Structure and Regeneration 

Study Section. 

Date: October 5–6, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton BWI (Baltimore), 1100 Old 

Elkridge Landing Road, Baltimore, MD 

21090. 

Contact Person: Yanming Bi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7814, Bethesda, MD 20892, 301–451– 

0996, ybi@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group 

Clinical, Integrative and Molecular 

Gastroenterology Study Section. 

Date: October 5, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Mayflower Park Hotel, 405 Olive 

Way, Seattle, WA 98101. 

Contact Person: Jonathan K Ivins, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2190, 

MSC 7850, Bethesda, MD 20892, (301) 594– 

1245, ivinsj@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group Macromolecular Structure and 

Function C Study Section. 

Date: October 5–6, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: William A Greenberg, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4168, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1726, greenbergwa@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group 

Prokaryotic Cell and Molecular Biology 

Study Section. 

Date: October 5–6, 2017. 

Time: 8:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Kinzie Hotel, 20 West Kinzie Street, 

Chicago, IL 60654. 

Contact Person: Dominique Lorang-Leins, 

Ph.D., Scientific Review Officer, National 

Institutes of Health, Center for Scientific 

Review, 6701 Rockledge Drive, Room 5108, 

MSC 7766, Bethesda, MD 20892, 

301.326.9721, Lorangd@mail.nih.gov. 

Name of Committee: Immunology 

Integrated Review Group, Cellular and 

Molecular Immunology—A Study Section. 

Date: October 5–6, 2017. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: David B Winter, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4204, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1152, dwinter@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR15–326: 

Imaging—Science Track Award for Research 

Transition (I/START). 

Date: October 5, 2017. 

Time: 12:00 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Yvonne Bennett, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5199, 

MSC 7846, Bethesda, MD 20892, 301–379– 

3793, bennetty@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 7, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–19361 Filed 9–12–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Board of Scientific 

Counselors, NHLBI. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Heart, Lung, and Blood 

Institute, including consideration of 

personnel qualifications and 


sradovich on DSK3GMQ082PROD with NOTICES